Abstract. In vivo imaging of cells tagged with light-emitting probes, such as firefly luciferase or fluorescent proteins, is a powerful technology that enables a wide range of biological studies in small research animals. Reporters with emission in the red to infrared (>600 nm) are preferred due to the low absorption in tissue at these wavelengths. Modeling of photon diffusion through tissue indicates that bioluminescent cell counts as low as a few hundred can be detected subcutaneously, while ϳ10 6 cells are required to detect signals at ϳ2 cm depth in tissue. Signal-to-noise estimates show that cooled back-thinned integrating charge coupled devices (CCDs) are preferred to imageintensified CCDs for this application, mainly due to their high quantum efficiency (ϳ85%) at wavelengths >600 nm where tissue absorption is low. Instrumentation for in vivo imaging developed at Xenogen is described and several examples of images of mice with bioluminescent cells are presented. © 2001 Society of Photo-Optical Instrumentation Engineers.
Introduction
The use of light-emitting probes, such as luciferase or fluorescent proteins, as a reporter of gene expression in living cells is a well-established technique for the study of biological activity. 1 Such probes have been widely used in vitro where light detection is easily accomplished using standard photomultiplier tubes or inexpensive charge coupled device ͑CCD͒ arrays for imaging applications. Detection of light-emitting probes in vivo within small living animals is also possible due to the semitransparent nature of mammalian tissue, [2] [3] [4] [5] but improved instrumentation is required, consisting of highsensitivity low-noise detectors, a more advanced imaging system, and sophisticated software tools for interpreting images.
The ability to track light-emitting cells in small laboratory animals such as mice or rats opens up a wide range of applications in pharmaceutical and toxicological research. These include in vivo monitoring of infectious diseases, tumor growth and metastases, transgene expression, compound toxicity, and viral infection or delivery systems for gene therapy. The ability to detect signals in real time in living animals means that the progression of a disease or biological process can be studied throughout an experiment with the same set of animals without the traditional need to sacrifice for each data point. This results in higher quality data using fewer animals and ultimately will speed the process of screening compounds leading to more rapid drug discovery.
Compared with more traditional structural imaging modalities such as magnetic resonance imaging ͑MRI͒ or computed tomography ͑CT͒, in vivo bioluminescent imaging offers several advantages. From a practical standpoint, bioluminescent/fluorescent imaging systems are lower cost, have shorter imaging times of Ͻ5 min, are easier to use by the nonspecialist, and can image multiple animals at once. In terms of quantitation, MRI/CT systems provide structural size information only, whereas bioluminescent signals provide information about both the location and number of metabolically active cells. Detection of infections in soft tissue such as bacterial pneumonia is also easily accomplished with bioluminescence and is not possible with MRI/CT. Finally, bioluminescent or fluorescent reporters linked to tissue-specific gene promoters provide functional and spatial information on gene expression, opening up an exciting area of research using light-producing transgenic animals.
In this paper, we examine the photonic issues associated with in vivo imaging and describe the design of instrumentation that has been optimized for this application. More specifically, we discuss briefly the tagging of cells with lightemitting markers and look at the trade-offs between bioluminescent and fluorescent probes. The basic physics issues associated with the diffusion of light through tissue are reviewed, along with the spectral properties of tissue. Design of in vivo imaging instrumentation and selection of a CCD is presented, using the general purpose in vivo imaging system ͑IVIS™͒ developed at Xenogen as an example. Finally, calibration and signal-to-noise issues are addressed, illustrated using several examples of in vivo images of mice. Most of the photon diffusion and instrumentation design issues discussed in this paper are common to both bioluminescence and fluorescence applications; however, the majority of calculations and image examples in the later part of this paper are for bioluminescent tags ͑luciferase͒ because that has been the focus of most of our work to date at Xenogen.
Light-Emitting Reporters
For most in vivo imaging applications, it is desirable to use genetic light-emitting reporters that propagate with the la-beled cells as they multiply in an animal. This avoids problems with signal dilution that would be associated with cell division when using exogenous dyes, for example. Luciferases and fluorescent proteins are two common genetic markers. The luciferase enzyme, when combined with the substrate luciferin, oxygen, and ATP, generates light through a chemical reaction resulting in bioluminescence. 1, 6 In the case of fluorescent proteins, the tagged cells must be illuminated with an excitation source in order to fluoresce.
Bioluminescence in mammalian ͑eukaryotic͒ cells is accomplished by incorporating the luc gene into the cell's DNA in order to express the luciferase enzyme. A required substrate, luciferin, is added exogenously and distributes quickly ͑within minutes͒ throughout the entire animal. The luc gene originates from the North American firefly, Photinus pyralis, and produces light at an emission peak at ϳ560 nm. In prokaryotic cells, the luciferase lux gene from soil bacterium ͑Photorhabdus luminescens͒ along with substrate-encoding genes are incorporated into the targeted cell so that both luciferase and luciferin are produced endogenously. The spectra for both types of luciferase are shown in Figure 1 . The firefly luciferase is especially attractive for in vivo imaging because the spectrum is very broad and contains a large component above 600 nm where transmission through tissue is higher ͑see Sec. 3͒.
Two common fluorescent proteins are green fluorescent protein and red fluorescent protein or DsRed. The excitation and emission spectra for each are shown in Figure 2 . Again, the DsRed is more attractive for in vivo applications because there is significant emission above 600 nm. Note, however, that the excitation remains in the 500-575 nm range where tissue absorption is very high.
Bioluminescence has an advantage over fluorescence as an in vivo reporter in that no external light source is required for excitation. This means that background levels are very low compared to those of fluorescent proteins where significant autofluorescence of the tissue surface results from the use of high power external excitation light sources, especially in cases where the luminescent cells are deep in the tissue. Another advantage of bioluminescence is that signals are more easily quantitated because, for tagged cells at a fixed location, the signal level observed on the surface of the animal is directly proportional to the number of cells. In the case of fluorescence, the signal level is related to both the number of cells and the intensity of excitation light, which is difficult to quantify because the excitation light is strongly absorbed as it passes into tissue. In most cases, fluorescent proteins require excitation in the green part of the spectrum where tissue absorption is particularly high. Despite these complications, researchers have made progress in developing diffuse optical tomography codes that treat the propagation of both the excitation and emission through tissue. 7 For in vitro applications, where cells are not embedded in tissue, fluorescent proteins have an advantage since they are usually brighter than bioluminescent reporters provided that the excitation source is bright enough. It is generally easier to observe individual cells in vitro using fluorescence compared with bioluminescence.
Photon Diffusion in Tissue
Mammalian tissue is a turbid medium that both scatters and absorbs photons. 8 Photons are scattered due to changes in refractive index at cell membranes and internal organelles. Absorption varies greatly with the type of cell or tissue, but is generally affected by the presence of hemoglobin, which absorbs strongly in the blue-green region of the visible spectrum, but is fairly transparent in the red at wavelengths Ͼ600 nm. Typically, for Ͼ600 nm, the 1/e absorption length is ϳ2 cm, while the effective length for scattering is much shorter at ϳ0.05 cm ͑see Refs. 8 and 9 for a review of the optical properties of tissue͒. In this regime, where scattering is dominant, a significant amount of bioluminescent emission can escape the tissue, but the emission is highly diffuse as illustrated schematically in Figure 3 .
In order to predict in vivo imaging signal levels and spatial resolution as a function of depth, and to help define the requirements for imaging instrumentation, it is important to have a quantitative model for the diffusion of photons in tissue. For the case of homogeneous tissue where the scattering length is short compared with the absorption length ͑generally true in tissue for Ͼ600 nm͒, photon propagation is well de- scribed by a diffusion model. 10 In this model, for continuous waves, the photon fluence ͑W/cm 2 ͒ decays exponentially away from a point source according to
where r is the distance away from the source, P is the source where j(r) is the flux, which is related to the fluence through j(r)ϭϪDٌ(r). Consider the case of an imaging system viewing down on a homogeneous slab of turbid media with an embedded source as shown in Figure 4 . The radiance observed at the tissue surface can be calculated from Eqs. ͑1͒ and ͑2͒ above with appropriate boundary conditions. Here we use the extrapolated boundary condition, 11 which is fairly simple and has been shown to agree well with Monte Carlo simulations and measurements. In this case, an image source is reflected about a plane located a distance z b above the surface as shown in Figure 4 , where
and R eff is the effective reflection coefficient averaged over all angles of incidence at the boundary. 11 The photon fluence at the boundary is the sum of the contribution from the source and its image
and the normal derivative of the fluence is given by
where r 1 ϭ͓ 2 ϩd 2 ͔ 1/2 and r 2 ϭ͓ 2 ϩ(dϩ2z b ) 2 ͔ 1/2 and d is the source depth. Inserting Eqs. ͑4͒ and ͑5͒ into Eq. ͑2͒ gives the surface radiance
ͬͮ . is plotted as a function of in Figure 5 for typical tissue scattering and absorption parameters. For comparison, a Monte Carlo calculation of the surface profile is also shown, performed using a modified version of the MCML code. 12 For these parameters the agreement between the Monte Carlo and the analytical diffusion model is quite good.
͑6͒
A real animal is neither homogeneous nor a slab shape, but, nevertheless, for source depths that are small compared to the radius of the animal, the above diffusion model can be used to get reasonably good qualitative estimates of signal level and spot size as a function of source depth. In Figure  6͑a͒ the peak radiance (ϭ0) obtained from Eq. ͑6͒ is plotted as a function of source depth for three sets of tissue parameters, corresponding roughly to green ͑550 nm͒, orange ͑590 nm͒, and red ͑650 nm͒ wavelengths. At a 1 cm depth the peak signal is attenuated by ϳ10
Ϫ2 for wavelengths at ϳ650 nm while the attenuation is very large ϳ10 Ϫ10 for shorter wavelengths ͑ϳ550 nm͒. Clearly, to observe signals from deep inside the tissue, it is essential to have high sensitivity in the red and near-infrared part of the spectrum. The spot size, or full width at half maximum, of the surface radiance profile is plotted in Figure 6͑b͒ . Although wavelengths Ͼ600 nm provide much higher signal levels, the trade-off is that the spot size is larger and hence spatial resolution is worse. We note that spatial resolution can actually be much better than the surface spot size indicated in Figure 6͑b͒ if we use the diffusion model with an appropriate fitting algorithm to reconstruct the location and size of the original internal light source.
The fact that the absorption coefficient a varies with wavelength results in a redshifting of the peak of the luciferase emission spectrum in vivo compared with in vitro. In Figure 7 we compare the yellow-green firefly ͑Photinus pyralis͒ luciferase spectrum measured in vitro in PBS with a subcutaneous tumor in vivo in a nude mouse. The host cell is the PC-3M-luc prostate tumor cell line. The strong attenuation of the signal at wavelengthsϽ600 nm is apparent and is characteristic of the hemoglobin absorption spectrum. In Figure 7 , the tumor is only ϳ0.5-1 mm deep so some of the emission below 600 nm is still present; however, for sources deeper in tissue, located in internal organs such as the liver, kidney, and lungs, the emission below 600 nm would be completely extinguished.
CCD Selection
Selection of the proper CCD camera is critical for in vivo imaging applications. As seen in Figures 6 and 7 , the CCD camera must have high sensitivity or quantum efficiency at wavelengths Ͼ600 nm and must have the lowest noise possible in order to detect sources up to a few centimeters deep. An image intensified photon counting CCD camera is one popular choice for many bioluminescent applications. The high-gain image intensifier allows individual photons to be counted with very little noise. However, these cameras, frequently equipped with bialkali photocathodes, suffer from relatively low quantum efficiency ͑QE͒ of just 10%-15% at 450 nm, dropping to less than 1% at 650 nm as shown in Figure 8 ͑Hamamatsu C2400-30 Series͒. Multialkali ͑S20͒ and GaAs photocathodes are available that have higher QE above 600 nm, but these tend to have higher thermal noise and cooling issues and are not readily available with large detector areas. Photon counting electronics associated with image intensified systems typically have an electronic threshold that eliminates subthreshold signals and reduces noise. It has been our observation that this threshold can effectively reduce the QE further. Another practical difficulty with photon counting systems is that the count rate is limited by pulse width and counting electronics considerations resulting in In vivo Imaging . . . limited dynamic range for bright signals. In this case, image brightness must be controlled through some external means such as apertures or neutral density filters.
A better CCD choice for in vivo applications is a cooled back-thinned ͑and back-illuminated͒ integrating CCD ͑e.g., Spectral Instruments 620 Series or Roper Scientific EEV 36-40b͒. These devices have very high quantum efficiency approaching 85% as shown in Figure 8 , and the QE remains high in the red and near-IR spectral regions. Dark current can be a source of noise with integrating CCDs, but cooling the CCD to Ϫ105°C reduces the dark current to near negligible levels, typicallyϽ4ϫ10 Ϫ4 e/s/pixel for 24 m pixels. Until recently, cooling detectors to Ϫ105°C required liquid nitrogen, but convenient cryogenic refrigerators have become available making operation at these temperatures relatively easy. There is also electronic noise associated with the CCD readout ͑read noise͒ of ϳ5 e rms that represents the minimum noise floor that the signal must exceed. Higher spatial resolution is another advantage of integrating CCDs. The Xenogen IVIS™ system typically uses a 25 mm CCD size with a 1024ϫ1024 format and 24 m pixels ͑formats 1300ϫ1340 with 20 m pixels and 2048ϫ2048 with 13.5 m pixels are also available͒.
Quantitative comparisons of image intensified versus integrating CCDs can be made by calculating the signal required to achieve a given signal-to-noise ratio for each device. The total noise for a given signal is the rms sum of the read noise, R N , the noise associated with dark charge, D c , and the statistical noise associated with the signal itself. 13 The signal and dark charge follow a Poisson distribution so the noise is simply the square root of the signal. The signal to noise can then be written as ͑all quantities are in units of electrons͒
where S e is the signal per pixel in electrons. Solving this equation for S e gives
The photon rate incident on a pixel is then given by S p ϭS e /(Q E ) where Q E is the quantum efficiency and is the integration time. Note that amplifier and digitizer noise can also be considered in calculating signal/noise ͑S/N͒ at the CCD digitizer output. However, these noise sources are usually negligible relative to the quantities in Eq. ͑7͒ and therefore are not included in this analysis. The signal in Eq. ͑7͒ can be increased relative to the read noise by binning pixels together prior to readout. A binning value of 5, for example, means that a 5ϫ5 group of pixels is summed together to form one larger superpixel. In this case, the superpixel has an area of 25 times the original pixel and hence 25 times the signal ͑and dark current͒. The read noise remains roughly constant as binning is increased, so binning effectively increases the ratio of signal to read noise. This trade-off of spatial resolution for sensitivity is usually beneficial for in vivo imaging where signal levels are low and the diffuse images do not demand high spatial resolution.
A comparison of S/N from Eq. ͑7͒ for integrating and intensified CCDs is shown in Figure 9 . For this figure we assume the high resolution CCD described above is binned to ϳ200ϫ200 pixels, i.e., binϭ5. For integrating CCDs we have R N ϳ5 electrons, D c ϳ0.01 electrons/pixel, and Q E ϳ0.85. Photon counting CCDs do not have a dark current specification, but for a typical 26 mm bialkali photocathode there is a thermal emission of ϳ10 electrons/s/image which gives an effective dark current of 2.5ϫ10 Ϫ4 electrons/pixel.
The read noise is assumed to be zero for the photon counting CCD and quantum efficiencies of 15% ͑ϳ450 nm͒ and 1.5% ͑ϳ600 nm͒ are plotted in Figure 9 for this device. For very low signals (S/Nϳ1), both the integrating and intensified (QEϭ15%) CCDs give similar performance. However, at S/Nϳ10, the intensified CCD requires about five times as much signal as the integrating CCD. Physically, what is happening here is that for S/Nϳ1 the higher QE of the integrating system combined with higher read noise ends up giving essentially the same S/N for the same signal as the intensified 
Fig. 9
Comparison of S/N for an integrating CCD (solid) and an intensified CCD (dashed). Two quantum efficiencies are plotted for the intensified CCD corresponding to ϭ450 nm (QEϭ15%) and ϭ600 nm (QEϭ1.5%).
Rice, Cable, and Nelson CCD. But as the S/N increases to 10, the read noise and dark charge noise become negligible compared with the signal noise itself, and so the higher QE of the integrating system ends up giving better performance. As seen in Figure 9 , at the red wavelengths of interest for in vivo imaging, the low QE gives very poor performance.
Imaging System Design
In consideration of the above arguments, a general purpose in vivo imaging system ͑IVIS™͒ has been developed at Xenogen based on a cooled back-illuminated integrating CCD. A schematic of the instrument is shown in Figure 10 . The CCD camera is located on top of a light-tight imaging chamber. The door to the chamber is made extremely light tight through the use of a double baffle seal while the remainder of the enclosure is constructed in such a way as to minimize any penetrations into the box. Light is collected from the specimen and imaged onto the CCD using a fast 50 mm f/1 lens. The sample stage moves up and down to vary the field of view ͑FOV͒ from 10-25 cm. A seven-position filter wheel is also provided to enable spectral imaging capability. The sample stage, lens focus, f/stop, and filter wheel are all stepper motor controlled through Xenogen's Living Image ® control software. Lightemitting diodes ͑LEDs͒ are located on the top plate to illuminate the specimen for photographic images. Other convenient features include a gas anesthesia system and a heated sample shelf to help maintain an animal's body temperature during anesthesia.
A typical in vivo image is shown in Figure 11 where 10 6 cells tagged with bacterial luciferase ͑Strep. pneumonia͒ were administered through the trachea with a ball-tipped needle. The sequence of steps required to produce this image can be summarized as follows. For the initial image ͑start of an experiment͒ bioluminescent cells are injected into the animal. If using firefly luciferase, then the luciferin substrate must also be injected prior to each image, while for bacterial luciferase the substrate is produced endogenously. The animal is then anesthetized with isoflurane and placed in the imaging chamber. A gas manifold with a nose cone is provided in the chamber to maintain anesthesia during imaging ͑see top of Figure  11͒ . In a typical image sequence, the LEDs are turned on and a photographic image is acquired and displayed with a grayscale color table, equivalent to black and white photograph. Then the LEDs are turned off and a longer exposure image of the bioluminescent ͑or fluorescent͒ light is taken. The bioluminescent image is overlaid on top of the photographic image using a pseudo-color intensity scale as seen in Figure 11 , where red indicates the highest intensity and violet the lowest intensity. The exposure time and f stop were 0.2 s, f/8 for the photographic image and 30 s, f/1 for the bioluminescent image. Note that the individual lobes of the lungs can be distinguished in this image. The units on the color bar in Figure 11 and all other images shown in this paper are analog-to-digital converter units, or ADU. The signal in ADU is related to the number of photoelectrons in a pixel by S ADU ϭS e G where G is the CCD amplifier gain. Typically, for the CCD cameras used in this study, Gϳ1 so it is appropriate to equate S ADU ϳS e .
Calibration and Signal-to-Noise Estimates
Absolute intensity calibration of the CCD camera and overall imaging system is necessary to calculate brightness ͑in physical units͒ of luminescent cells and to estimate the number of cells inside an animal from the intensity of the surface image. To accomplish this, we utilize an absolutely calibrated 8 in. integrating sphere from Optronic Laboratories, Inc. ͑OL Series 425 Variable Low-Light-Level Calibration Standard͒. The integrating sphere is illuminated with a tungsten lamp, and the light level entering the sphere can be controlled using a set of reducing apertures and by moving the lamp away from the aperture. This combination allows very low radiance levels of ϳ10 Ϫ10 W/cm 2 /sr (srϭsteradian) across the 2 in. output aperture of the sphere. By imaging this aperture, counts detected by the CCD camera digitizer ͑ADU͒ can be converted to physical units of radiance in W/cm 2 /sr or photons/s/cm 2 /sr. The camera calibration depends on f-stop and shelf position. A typical calibration for a wide open lens ͑f/1͒ and a 15 cm FOV is 4ϫ10 5 photons/s/sr/cm 2 at the object plane per ADU/ s/pixel at the CCD ͑for 24 m pixel size and ϭ600 nm.͒ To give an example of sensitivity, if we assume a 5 min image with binning of 8 ͑64 pixels grouped together to form a larger pixel͒ and a total noise of 7 ADU per binned pixel, then the minimum detectable radiance is The area of a binned pixel in the object plane ͑object-to-image demagnificationϭ5.8͒ for this configuration is 0.013 cm 2 , so the minimum detectable photon emission into 4 steradians ͑e.g., from an isotropically radiating cell͒ is 24 photons/s/ pixel. The bioluminescent emission per cell varies depending on the cell line, but in the cell lines we have measured to date emission is in the range of 5-100 photons/s/cell into 4 steradians. Thus the IVIS™ imaging system can detect on the order of 0.25-5 cells per pixel in vitro with a S/Nϳ1.
An in vitro image of a 96-well plate containing a dilution series of bioluminescent bacteria ͑Pseudomonas aeruginosa͒ is shown in Figure 12 . The cell count per well ranges from 5000 down to 150. The 150-count well is barely visible above the CCD noise and represents the minimum detectable number of cells for this particular cell line in a 96-well plate. There are about 60 binned (binϭ10) pixels in a well giving ϳ2.5 cells per pixel sensitivity in this case, consistent with the discussion above.
Of particular interest to the application of in vivo imaging is the minimum observable cell as a function of depth in an animal. The number of CCD signal electrons, S e , required to give a certain signal-to-noise ratio, S N , is given by Eq. ͑8͒. We can combine this with Eq. ͑6͒ to find the minimum number of cells that can be detected at a depth d. Defining a normalized radiance as L n ϵL zϭ0 / P and replacing the emission power P with the integrated photon count, which is given by C n c where C n is the number of bioluminescent cells, c is the photon emission rate per cell, and is the integration time, we can write
where dA is the pixel area element at the object plane, d⍀ is the collection solid angle which is assumed small. Substituting Eq. ͑8͒ for S e and solving for C n gives
This equation gives the number of cells required to give a signal-to-noise ratio S N at a depth d in tissue. In Figure 13 we plot the cell count versus depth for S N values of 1, 10, and 100 for two different absorption coefficients of 0.25 and 1.0 cm Ϫ1 ͑corresponding roughly to wavelengths of 650 and 590 nm, respectively͒. We set ϭ300 s, c ϭ30 photons/cell/s, and used 24 m pixels with binϭ8 for this plot. According to this calculation, for cells ϳ0.5 mm deep ͑subcutaneous͒, we can detect on the order of a few hundred cells with S N ϳ10.
To make measurements at the deepest organs in a mouse ͑ϳ1 cm deep͒ at red wavelengths requires 10 4 -10 5 cells. For shorter wavelengths ͑see a ϭ1 cm Ϫ1 curves͒ significantly more cells are required to see deep tissue signals. These results provide general guidance on the minimum number of detectable cells; the exact number will depend on the brightness of the cell line and the type of tissue the photons must pass through.
The results from Figure 13 are in good agreement with measurements in real animals. In Figure 14͑a͒ we show images of PC3M-luc prostate tumor cells injected subcutaneously into a nude mouse. Cell counts of 500, 1000, 10 4 , and 10 5 were injected into the thigh of each animal. In this case, 500 cells is close to the minimum cell count that can be observed. The sum of the counts in an Region of Interest ͑ROI͒ surrounding each spot is plotted in Figure 14͑b͒ . For comparison, in vitro measurements of the same cell counts are also shown in Figure 14͑b͒ . A deep-source lung signal is shown in Figure 15 . For this animal, 4ϫ10 6 PC3M-luc cells were injected into a tail vein, where cells are promptly transported to the lungs. The peak signal levels and signal-to-noise values from both Figures 14 and 15 are given in Table 1 . The signal units in this table are ADU, but since the CCD amplifier gain is ϳ1 we can assume S ADU ϳS e for comparison with Figure  13 . Although the data in Table 1 are limited, the S/N versus depth trend is in qualitative agreement with that predicted in Figure 13 .
The signal-to-noise calculations above only consider the CCD and intrinsic signal noise. In addition, there can be other In vivo Imaging . . .
sources of background light that create what is effectively a higher noise floor. As seen in Figure 14͑a͒ , background light can be observed on the animal with the 500-cell injection. This background level is small and is usually only a factor when looking for the very lowest bioluminescent signals. The background emission can result from phosphorescence of the skin, fur, or impurities on the animal. There also appears to be a low-level light emission due to metabolic activity in live animals, although this is not very well understood at the present time. Regardless of the source, every effort must be made to reduce the background light in order to approach the intrinsic noise floor of the CCD camera.
As a final example of the power of in vivo imaging, we show an example of tumor metastases in Figure 16 . Here 5 ϫ10
6 breast cancer cells ͑MDA-MB-231-luc͒ were injected into a tail vein and this image was taken at week 14 after injection. The image shows clear metastatic signals from the lungs and lower body organs. These tumors are small and certainly would not have been palpable externally. The animal was dissected shortly after this image was taken, and ex vivo signals were found in the lungs, spine, adrenal glands, and lymph nodes.
Conclusion
In vivo imaging of cells or viruses tagged with light-emitting probes promises to be an important technology for the study of biological activity, the screening of potential drugs, and the assessment of toxicological effects of compounds. Both bioluminescent luciferase and fluorescent proteins are potential tags that can be used, although bioluminescence has a significant advantage due to extremely low backgrounds. Longwavelength ͑Ͼ600 nm͒ probes will give the best signal levels in mammalian tissue due to lower absorption in tissue. The use of state-of-the-art cooled integrating CCD cameras along with imaging chambers optimized for in vivo applications allow the detection of bioluminescent signals throughout the body of small laboratory animals such as mice or rats. Experiments with luciferase tagged cells have demonstrated that minimum cell counts in the range of ϳ500 cells can be detected subcutaneously, while higher cell counts are required for larger depths in tissue. The sensitivity of detection is adequate to observe metastases of cancer cells, demonstrating the potential of in vivo imaging technology.
